NielsenIQ segments new consumers who have started taking the medication in the latest 1-3 months, 4-6 months, and 7-11 months, and interestingly, in the latest 1-3 month data set, the newest users index even younger
Most patients achieve stable, improved A1C within 2024 weeks and maintain that improvement long-term with consistent dosing
This growth was driven by continued demand across both relapsing and primary progressive MS indications, particularly in the US, where sales rose by 5%, and in Europe, with a 14% increase, notably in the UK and Germany
What is the best app to track GLP-1 medications
Glutathione IV vs NAD IV: Which One Fits Your Goals
Studies show that approximately one percent of pharmacy costs are attributable to fraud, waste, and abuse, amounting to billions of dollars in unnecessary costs